Enter your terms above and click the 'Search' button.

Showing articles 0 to 13 of 13 Filter Applied: gammaglobulin therapy,intravenous (Click to remove) Clinical Pathologic Conference, West Nile Virus Encephalitis NEJM 377:1878-1886, Case 34-2017, 2017 Diagnosis and Management of the Antiphospholipid Syndrome BMJ 340:1125-1132, Cohen,D., et al, 2010 Incidence and Mortality Rates of Myasthenia Gravis and Myasthenic Crisis in US Hospitals Neurol 72:1548-1554, Alshekhlee,A.,et al, 2009 Guillain-Barre Syndrome BMJ 337:227-231, Winer,J.B., 2008 Intensive Care of the Myasthenic Patient Neurol 48 (Suppl 5) :S70-S75997., Mayer,S.A., 1997 Myasthenia Gravis NEJM 330:1797-1810, Drachman,D.B., 1994 Myasthenia Gravis in Mothers and Their Newborns Clin Obstet Gynecol 34:82-99, Plauche,W.C., 1991 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Autoimmune Encephalitides: A Broadening Field of Treatable Conditions Neurologist 22:1-13, Kalman, B., 2017 Morvan Syndrome: Clinical and Serological Observations in 29 Cases Ann Neurol 72:241-255, Irani, S.R.,et al, 2012 Idiopathic Dysautonomia Treated with Intravenous Gammaglobulin Lancet 347:28-29, Heafield,M.T.E.,et al, 1996 Intravenous IgG in Guillain-Barre Syndrome BMJ 313:376-377, Hughes,R.A.C., 1996 Epstein-Barr Virus-Associated Acute Autonomic Neuropathy Ann Neurol 40:453-455, Bennett,J.L.,et al, 1996 Showing articles 0 to 13 of 13